257 related articles for article (PubMed ID: 19323585)
1. Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents.
Ilowite J; Spiegler P; Kessler H
Drugs; 2009; 69(4):407-19. PubMed ID: 19323585
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
King P
Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
[TBL] [Abstract][Full Text] [Related]
3. Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasis.
Athanazio R; da Costa JC; de la Rosa Carrillo D; Martínez-García MÁ
Expert Rev Respir Med; 2018 Jul; 12(7):569-584. PubMed ID: 29806511
[TBL] [Abstract][Full Text] [Related]
4. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
[TBL] [Abstract][Full Text] [Related]
5. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of non-cystic fibrosis bronchiectasis].
Martínez García MÁ; Máiz Carro L; Catalán Serra P
Arch Bronconeumol; 2011 Dec; 47(12):599-609. PubMed ID: 21798654
[TBL] [Abstract][Full Text] [Related]
7. Inhaled hyperosmolar agents for bronchiectasis.
Wills P; Greenstone M
Cochrane Database Syst Rev; 2006 Apr; (2):CD002996. PubMed ID: 16625566
[TBL] [Abstract][Full Text] [Related]
8. The use of antiinflammatory therapy and macrolides in bronchiectasis.
Feldman C
Clin Chest Med; 2012 Jun; 33(2):371-80. PubMed ID: 22640852
[TBL] [Abstract][Full Text] [Related]
9. Inhaled hyperosmolar agents for bronchiectasis.
Wills P; Greenstone M
Cochrane Database Syst Rev; 2002; (1):CD002996. PubMed ID: 11869647
[TBL] [Abstract][Full Text] [Related]
10. Inhaled hyperosmolar agents for bronchiectasis.
Wills P; Greenstone M
Cochrane Database Syst Rev; 2001; (2):CD002996. PubMed ID: 11406058
[TBL] [Abstract][Full Text] [Related]
11. Emerging drugs for bronchiectasis.
Chang AB; Marsh RL; Smith-Vaughan HC; Hoffman LR
Expert Opin Emerg Drugs; 2012 Sep; 17(3):361-78. PubMed ID: 22809423
[TBL] [Abstract][Full Text] [Related]
12. Rational use of mucoactive medications to treat pediatric airway disease.
Linssen RSN; Ma J; Bem RA; Rubin BK
Paediatr Respir Rev; 2020 Nov; 36():8-14. PubMed ID: 32653467
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic agents for mucus clearance in bronchiectasis.
Nair GB; Ilowite JS
Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
[TBL] [Abstract][Full Text] [Related]
14. New therapeutic options for noncystic fibrosis bronchiectasis.
Yap VL; Metersky ML
Curr Opin Infect Dis; 2015 Apr; 28(2):171-6. PubMed ID: 25692269
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological treatment of COPD and future of anti-inflammatory therapy].
Watz H; Bitter-Suermann S; Kanniess F; Magnussen H
Med Klin (Munich); 2006 Apr; 101(4):283-92. PubMed ID: 16607484
[TBL] [Abstract][Full Text] [Related]
16. New treatment options for bronchiectasis.
Metersky ML
Ther Adv Respir Dis; 2010 Apr; 4(2):93-9. PubMed ID: 20388725
[TBL] [Abstract][Full Text] [Related]
17. [Management of bronchiectasis antibiotic therapy excepted. Non-antibiotic therapy of children and adults].
Kalendarov D; Hubert D
Rev Pneumol Clin; 2001 Sep; 57(4 Pt 2):S31-5; discussion S35-6. PubMed ID: 11887437
[No Abstract] [Full Text] [Related]
18. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
19. Investigational inhaled therapies for non-CF bronchiectasis.
Antoniu SA
Expert Opin Investig Drugs; 2018 Feb; 27(2):139-146. PubMed ID: 29338445
[TBL] [Abstract][Full Text] [Related]
20. Management of Non-Cystic Fibrosis Bronchiectasis.
Dull SK; Havlat BD; Sanley MJ; Malesker MA
Consult Pharm; 2018 Nov; 33(11):658-666. PubMed ID: 30458908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
